Baymark Health Services Opens Applegate Recovery in Thibodaux, LA

New AppleGate center expands accessibility of proven outpatient treatment with Suboxone® for opioid addiction.

AppleGate Recovery, a division of BayMark Health Services, announced the expansion of opioid addiction treatment services in Louisiana with the opening of an outpatient facility in Thibodaux, LA. AppleGate now offers evidence-based medication-assisted treatment (MAT) with buprenorphine or Suboxone® and in-house counseling at 12 clinics in 5 states, including the 5 locations now serving residents across Louisiana. Additional sites are planned for opening by the end of the year.

“As heroin and fentanyl usage increases and the number of overdose deaths rise with it, AppleGate strives to combat the disease of addiction with proven treatment options,” shared Dr. Philip Isherwood, Medical Director of AppleGate Recovery. “We’ve found medication-assisted treatment to be very effective, particularly when patients take advantage of in-house counseling. I have witnessed many patients achieve meaningful recovery from the disease of addiction and restore their lives.”

AppleGate Recovery Thibodaux medical providers utilize buprenorphine and buprenorphine compounds, also known by the brand names Suboxone® Zubsolv®, Bunavail® to help patients control withdrawal symptoms and cravings for opioids. In addition to medication services,
AppleGate provides counseling, lab services and case management. This proven treatment model wraps supportive services around medication to address both the physical addition as well as the causes and consequences of that addiction.

Located at 2000 Audobon Avenue, Suite C, Thibodaux, LA 70301, AppleGate Recovery Thibodaux is open 9am-5pm Monday through Thursday and 9am-4pm on Fridays.

For more information, visit: www.AppleGateRecovery.com or to schedule an appointment call 225.208.2000.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to more than 50,000 patients in recovery from substance use disorder across the United States and Ontario, Canada. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances. The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.